搜索
MoonLake Immunotherapeutics
MLTX添加自选
18.440USD
-0.550-2.90%
收盘 07-31 16:00（美东）报价延迟15分钟
1.52B总市值
亏损市盈率 TTM
关于 MoonLake Immunotherapeutics 公司
MoonLake Immunotherapeutics, formerly known as Helix Acquisition Corp, is a Switzerland-based company engaged in the healthcare industry. The Firm is a clinical-stage biopharmaceutical company focused on the development of medicines for immunologic diseases, including inflammatory skin and joint diseases. The Company develops tri-specific nanobody Sonelokimab (SLK) which purpose is to target and penetrate difficult-to-reach inflamed tissues. SLK is a molecule with enhanced enrichment in deep skin & joints and binding of targets. SLK inhibits IL-17A and IL-17F inhibition to treat inflammatory diseases, by independently inhibiting the naturally-occurring IL-17 A/A, A/F and F/F dimers that drive inflammation in patients.
MoonLake Immunotherapeutics简介
公司代码MLTX
公司名称MoonLake Immunotherapeutics
上市日期Oct 20, 2020
CEOSantos Da Silva (Jorge)
员工数量100
证券类型Ordinary Share
年结日Oct 20
公司地址Dorfstrasse 29
城市ZUG
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Switzerland
邮编6300
电话41415108022
网址https://moonlaketx.com/
公司代码MLTX
上市日期Oct 20, 2020
CEOSantos Da Silva (Jorge)
MoonLake Immunotherapeutics公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Kristian Reich
Dr. Kristian Reich
Chief Scientific Officer
Chief Scientific Officer
3.01M
+1.63%
Mr. Matthias Bodenstedt
Mr. Matthias Bodenstedt
Chief Financial Officer
Chief Financial Officer
1.12M
-5.11%
Mr. Simon Sturge
Mr. Simon Sturge
Independent Chairman of the Board
Independent Chairman of the Board
171.98K
--
Dr. Andrew J. Phillips
Dr. Andrew J. Phillips
Independent Director
Independent Director
--
--
Dr. Jorge Santos Da Silva
Dr. Jorge Santos Da Silva
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Spike N. Loy, J.D.
Mr. Spike N. Loy, J.D.
Independent Director
Independent Director
--
--
Ms. Catherine Moukheibir
Ms. Catherine Moukheibir
Independent Director
Independent Director
--
--
Dr. Ramnik Xavier
Dr. Ramnik Xavier
Independent Director
Independent Director
--
--
Dr. Atif Khan
Dr. Atif Khan
Director - Strategic Planning and Projects
Director - Strategic Planning and Projects
--
--
名称
名称/职务
职务
持股
持股变动
Dr. Kristian Reich
Dr. Kristian Reich
Chief Scientific Officer
Chief Scientific Officer
3.01M
+1.63%
Mr. Matthias Bodenstedt
Mr. Matthias Bodenstedt
Chief Financial Officer
Chief Financial Officer
1.12M
-5.11%
Mr. Simon Sturge
Mr. Simon Sturge
Independent Chairman of the Board
Independent Chairman of the Board
171.98K
--
Dr. Andrew J. Phillips
Dr. Andrew J. Phillips
Independent Director
Independent Director
--
--
Dr. Jorge Santos Da Silva
Dr. Jorge Santos Da Silva
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Spike N. Loy, J.D.
Mr. Spike N. Loy, J.D.
Independent Director
Independent Director
--
--
常见问题
MoonLake Immunotherapeutics的前五大股东是谁？
MoonLake Immunotherapeutics 的前五大股东如下：Dr. Kristian Reich
有多少机构持有MoonLake Immunotherapeutics(MLTX)的股份？
截至2026Q1，共有358家机构持有MoonLake Immunotherapeutics的股份，合计持有的股份价值约为54.44M，占公司总股份的74.73%。与2025Q4相比，机构持股有所增加，增幅为-3151979.00。